Amerika Serikat - Inggris - NLM (National Library of Medicine)

blenheim pharmacal, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations ( 8.4)] , nursing mothers [see use in specific populations ( 8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions ( 5.4)] - glaucoma [see adverse reactions ( 6.3) and drug interactions ( 7.1)] - obstructive uropathy [see warnings and precautions ( 5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions ( 5.5)] - severe ulcerative colitis [see warnings and precautions ( 5.7)] - reflux esophagitis pregnancy c

Amerika Serikat - Inggris - NLM (National Library of Medicine)

dispensing solutions, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions  (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies b

Amerika Serikat - Inggris - NLM (National Library of Medicine)

rebel distributors corp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride tablets and capsules are indicated for the treatment of functional bowel/ irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients. ) - nursing mothers (see warnings and precautions: information for patients .) abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

Amerika Serikat - Inggris - NLM (National Library of Medicine)

life line home care services, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

Amerika Serikat - Inggris - NLM (National Library of Medicine)

state of florida doh central pharmacy - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions.) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients.) abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

state of florida doh central pharmacy - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

Amerika Serikat - Inggris - NLM (National Library of Medicine)

physicians total care, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients . ) - nursing mothers (see warnings and precautions: information for patients . ) abuse and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

stat rx usa - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of this formulation - infants less than 6 months of age (see warnings and precautions : information for patients .) - nursing mothers (see warnings and precautions : information for patients .)

Amerika Serikat - Inggris - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see  use in specific populations ( 8.4)] , nursing mothers [see  use in specific populations ( 8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see  warnings and precautions ( 5.4)] - glaucoma [see  adverse reactions ( 6.3) and  drug interactions  ( 7.1)] - obstructive uropathy [see  warnings and precautions ( 5.8)] - obstructive disease of the gastrointestinal tract [see  warnings and precautions ( 5.5)] - severe ulcerative colitis [see  warnings and precautions ( 5.7)] - reflux esophagitis teratogenic effects: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of